Actemra

Actemra MIMS Class

tocilizumab

Manufacturer:

Roche

Marketer:

DKSH
Full Prescribing Info
MIMS Class
Disease-Modifying Anti-Rheumatic Drugs (DMARDs) / Immunosuppressants
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $139 a year.
Sign up for free
Already a member? Sign in